|
LASTAVIN 80
Colloidal Anhydrous silica (Aerosil 200) 1.700 mg/6 mL,Croscarmellose sodium ( Ac-di-sol Type SD 711) 4.817 mg/6 mL,Instacoat EHP 250 A10R00391 Pink 5.000 mg/6 mL,Magnesium Stearate 1.700 mg/6 mL,Microcrystalline Cellulose (Avicel PH 101) 61.950 mg/6 mL,Microcrystalline cellulose 102 11.333 mg/6 mL,Povidone (Kollidon 30) 8.500 mg/6 mL,Purified Water q.s mg/6 mL,Valsartan 80 mg/6 mL
|
Film Coated Tablet
|
Tanzania
|
TAN 24 HM 0160
|
Registered/Compliant
|
|
LASTAVIN AM 10/160
Amlodipine 10 mg, Valsartan 160 mg
|
Film Coated Tablets
10 mg, 160 mg
|
Rwanda
|
Rwanda FDA-HMP-MA-1402
|
Registered
|
|
LASTAVIN AM 10/160
Amlodipine Besylate 10 mg/6 mL,Colloidal Anhydrous silica (Aerosil 200) 3.400 mg/6 mL,Crospovidone (Kollidon CL) 9.634 mg/6 mL,Instacoat EHP 250 A10R00393 Brown 10.000 mg/6 mL,Magnesium Stearate 3.400 mg/6 mL,Microcrystalline cellulose ( Avicel PH 102 ) 18.800 mg/6 mL,Microcrystalline cellulose (Avicel PH101) 79.898 mg/6 mL,Povidone (PVPK-30) 17.000 mg/6 mL,Purified Water q.s -,Sodium Starch Glycolate Type A 34.000 mg/6 mL,Valsartan 160 mg/6 mL
|
Film Coated Tablet
|
Tanzania
|
TAN 23 HM 0361
|
Registered/Compliant
|
|
LASTAVIN AM 5/160
Amlodipine Besylate 5 mg/6 mL,Colloidal Anhydrous silica (Aerosil 200) 3.400 mg/6 mL,Crospovidone (Kollidon CL) 9.634 mg/6 mL,Ferric Oxide Yellow (Yellow Iron Oxide /Idacol Yellow Oxide of Iron/Sicovit Yellow 10) 0.300 mg/6 mL,Instacoat EHP 250 A10R00390 Beige 10.000 mg/6 mL,Magnesium Sterate 3.400 mg/6 mL,Microcrystalline cellulose (Avicel PH101) 86.532 mg/6 mL,Microcrystalline cellulose 102 18.800 mg/6 mL,Povidone (PVPK-30) 17.000 mg/6 mL,Purified Water q.s -,Sodium Starch Glycolate (Type A) 34.000 mg/6 mL,Valsartan 160 mg/6 mL
|
Film Coated Tablet
|
Tanzania
|
TAN 25 HM 0150
|
Registered/Compliant
|
|
LASTAVIN AM PLUS 10/160/12.5
Amlodipine Besylate 10 mg/6 mL,Colloidal Anhydrous Sillica ( Aersol 200) 1.700 mg/6 mL,Croscarmellose Sodium 9.633 mg/6 mL,Hydrochlorothiazide 12.5 mg/6 mL,Magnesium Stearate 3.400 mg/6 mL,Microcrystalline Cellulose 101 112.526 mg/6 mL,Povidone K -30 (Kollidon 30) 17.000 mg/6 mL,Purified Water q.s ml,Tabcoat TC-565048 Brown 10.000 mg/6 mL,Valsartan USP 160 mg/6 mL
|
Film Coated Tablet
10
|
Tanzania
|
TAN 25 HM 0155
|
Registered/Compliant
|
|
LASTAVIN AM PLUS 5/160/25
Amlodipine 5 mg/6 mL,Colloidal Anhydrous Sillica ( Aersol 200) 1.700 mg/6 mL,Croscarmellose Sodium (AcDiSol Type – SD 711) 9.633 mg/6 mL,Hydrochlorothiazide 25 mg/6 mL,Instacoat EHP 250 A10R00391 Pink 10.000 mg/6 mL,Magnesium Sterate 3.400 mg/6 mL,Microcrystalline cellulose Avicel PH 101 106.960 mg/6 mL,Microcrystalline cellulose PH 102 22.673 mg/6 mL,Povidone K-30 17.000 mg/6 mL,Purified Water q.s ml,Valsartan USP 160 mg/6 mL
|
Film Coated Tablet
|
Tanzania
|
TAN 25 HM 0048
|
Registered/Compliant
|
|
LASTAVIN HTZ 160/12.5
VALSARTAN AND HYDROCHLOROTHIAZIDE USP
|
TABLETS
160 MG/12.5 MG
|
Rwanda
|
Rwanda FDA-HMP-MA-2349
|
Registered
|
|
LASTAVIN HTZ 160/12.5
Colloidal anhydrous silica 3.400 mg/6 mL,Croscarmellose sodium ( Ac-di-sol Type SD 711) 9.633 mg/6 mL,Hydrochlorothiazide 12.5 mg/6 mL,Magnesium Sterate - mg/6 mL,Magnesium stearate (vegetable) 3.400 mg/6 mL,Microcrystalline Cellulose (PH102) 22.667 mg/6 mL,Microcrystalline cellulose (Avicel PH101) 111.400 mg/6 mL,Povidone (PVPK-30) 17.000 mg/6 mL,Purified Water q.s -,Tabcoat TC 565048 Brown 10.000 mg/6 mL,Valsartan 160 mg
|
Tablets
|
Tanzania
|
TAN 24 HM 0074
|
Registered/Compliant
|
|
LASTAVIN HTZ 80/12.5
VALSARTAN AND HYDROCHLOROTHIAZIDE USP
|
TABLETS
80 MG/12.5 MG
|
Rwanda
|
Rwanda FDA-HMP-MA-2348
|
Registered
|
|
LASTAVIN HTZ 80/12.5
Colloidal Anhydrous silica (Aerosil 200) 0.850 mg/6 mL,Colloidal anhydrous silica 0.850 mg/6 mL,Croscarmellose Sodium (AcDiSol Type – SD 711) 4.816 mg/6 mL,Hydrochlorothiazide 12.5 mg/6 mL,Magnesium Stearate - mg/6 mL,Magnesium Stearate 1.700 mg/6 mL,Microcrystalline Cellulose (Avicel pH 102) 11.334 mg/6 mL,Microcrystalline cellulose (Avicel PH101) 49.450 mg/6 mL,Povidone (PVPK-30) 8.500 mg/6 mL,Purified Water q.s -,Tabcoat TC 565048 Brown 5.000 mg/6 mL,Valsartan 80 mg/6 mL
|
Tablets
|
Tanzania
|
TAN 24 HM 0075
|
Registered/Compliant
|
|
LEVOTOP PF
Borax 1.000 mg/vial,Boric Acid 10.000 mg/vial,HYDROXYPROPYL BETADEX 5.000 mg/vial,Hydrochloric acid 20.000 mg/vial,Levofloxacin (Hemihydrate) 15 mg/ml,Sodium Chloride 2.500 mg/vial,Water for Injection q.s. mg/vial
|
Ophthalmic Solution
1.5
|
Tanzania
|
TAN 23 HM 0181
|
Registered/Compliant
|
|
LEVOTOP PF 1.5% EYE DROPS
Levofloxacin
|
Ophthalmic Solution
1.5% w/v
|
Rwanda
|
Rwanda FDA-HMP-MA-2309
|
Registered
|
|
Lacoma
Anhydrous Disodium hydrogen Phosphate 1.000 mg/6 mL,Benzalkonium chloride 0.200 mg/6 mL,Latanoprost 50 mcg/ml,POLYOXYL 40 HYDROGENATED CASTOR OIL 5.00 mg/6 mL,Potassium Dihydrogen Phosphate 1.000 mg/6 mL,Sodium Chloride. 6.900 mg/6 mL,Water for injections q.s ml
|
Ophthalmic Solution
50
|
Tanzania
|
TAN 25 HM 0619
|
Registered/Compliant
|
|
Lacoma T Eye drops
Latanoprost 50 mcg,Timolol Meleate equivalent to Timolol 5 mg/ml
|
Eye Drops
5 mg/ml,50 mcg
|
Zambia
|
115/049
|
Registered/Compliant
|
|
Lacoma Eye Drops
Latanoprost 0.050 mg/ml
|
Opthalmic liquid
0.050 mg/ml
|
Zambia
|
115/082
|
Registered/Compliant
|
|
Lastavin 160
Colloidal Anhydrous silica (Aerosil 200) 3.400 mg,Croscarmellose sodium ( Ac-di-sol Type SD 711) 9.634 mg,Instacoat EHP 250 A10R00391 Pink 10.000 mg/6 mL,Magnesium Stearate 3.400 mg/6 mL,Microcrystalline Cellulose (102) 22.666 mg/6 mL,Microcrystalline Cellulose BP (PH 101) 123.900 mg/6 mL,Povidone K 30 (Kollidon) 17.000 mg/6 mL,Purified water USP/BP/ Ph.Eur. /IP/IH. q.s mg/6 mL,Valsartan USP 160 mg
|
Film Coated Tablet
160
|
Tanzania
|
TAN 26 HM 0105
|
Registered/Compliant
|
|
Levotop PF 1.5%
Levofloxacin Hemihydrate 15.370 mg
|
Eye Drops
15.370 mg
|
Zambia
|
ZAMRA-HM-26-202
|
Registered/Compliant
|
|
Lotel gel
1.2-propanediol 4.400 mg/6 mL,Benzalkonium chloride 0.030 mg/6 mL,Boric Acid 5.000 mg/6 mL,Disodium Edetate Dihydrate 0.550 mg/6 mL,Glycerol. 8.800 mg/6 mL,Hydrochloric acid q.s mg/6 mL,Sodium Chloride 0.500 mg/6 mL,Sodium Hydroxide, q.s mg/6 mL,Tyloxapol 0.500 mg/6 mL,Water for Injection q.s mg/6 mL,loteprednol etabonate 0.5 %w/w,polycarbophil AA1 3.750 mg/6 mL
|
Ophthalmic Ointment
0.5
|
Tanzania
|
TAN 24 HM 0459
|
Registered/Compliant
|
|
MOMADERM
Mometasone Furoate Cream USP 0.1% w/w
|
Cream
0.1% w/w
|
Rwanda
|
Rwanda FDA-HMP-MA-1129
|
Registered
|
|
MOMADERM
Benzyl alcohol 10.000 mg/6 mL,Cetomacrogol 1000 50.000 mg/6 mL,Cetostearyl Alcohol 70.000 mg/6 mL,Citric Acid Monohydrate 0.500 mg/6 mL,Disodium Edetate 0.500 mg/6 mL,Light Liquid Paraffin 180.000 mg/6 mL,Mometasone furoate 0.1 % w/w,Propylene Glycol 100.000 mg/6 mL,Purified Water 587.500 mg/6 mL,Sodium Thiosulphate 0.500 mg/6 mL
|
Cream
|
Tanzania
|
TAN 22 HM 0379
|
Registered/Compliant
|